Testosterone is the most prescribed hormone in a men’s health telemedicine practice and among the most clinically impactful interventions in both men’s and women’s hormone optimization. But testosterone is also a Schedule III controlled substance — and prescribing it via telehealth carries specific regulatory requirements that practitioners must understand before seeing their first patient.
The DEA requires practitioners who prescribe controlled substances via telemedicine — including testosterone — to have a DEA registration that is valid in the state where the patient is located. The Ryan Haight Act of 2008 established that a practitioner must conduct at least one in-person medical evaluation before prescribing Schedule III–V controlled substances via telemedicine to that patient, with exceptions for practitioners operating through DEA-registered telemedicine platforms or in specific regulatory contexts. The DEA’s more recent Special Registration rulemaking has been developing a pathway for registered telemedicine platforms that would allow prescribing without an initial in-person visit — practitioners should check current DEA guidance as this regulatory framework continues to evolve.
Clinically, testosterone prescribing for telehealth patients requires comprehensive baseline labs (total and free testosterone, estradiol, SHBG, LH, FSH, CBC with hematocrit, PSA for men over 40, and a comprehensive metabolic panel), a detailed clinical history and symptom assessment, and a documented clinical rationale for therapy. Follow-up labs at 6–8 weeks post-initiation (testosterone, hematocrit, estradiol) are clinically necessary and regulatory-compliance relevant — document everything.
Delivery form selection matters both clinically and from a patient convenience standpoint. Weekly or twice-weekly subcutaneous testosterone cypionate injections (0.1–0.2ml subcutaneous, not IM, for most telehealth patients who self-inject) are the most flexible and adjustable form. Transdermal creams are a convenient alternative but have potential transference concerns. Pellets are placed in-office — a consideration if you are purely telehealth without a physical location.
Our Practitioner Training covers testosterone prescribing protocols and regulatory compliance. Book your session here or call 844-734-2112.
Ready to build your own telemedicine hormone clinic?
Clinic In A Box™ is our 3-month, done-with-you program to launch and scale your own practice — systems, compliance, labs, pharmacy, and patient acquisition, all built with you.